EPISODE · Jun 4, 2026 · 1 MIN
Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer
from TheBrief.Health · host TheBrief.Health
Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.
What this episode covers
Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.
NOW PLAYING
Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m